3
News
24th March 2020

COVID-19: A conversation with Suerie Moon

Suerie Moon and Global Health Centre
310
Events
3 July, 2020

COVID-19 in Developing Economies: What consequences can we anticipate and what effects can we mitigate?

Ugo Panizza
3
Publications
Journal article, 30 April, 2019

The legal determinants of health harnessing the power of law for global health and sustainable development

Gian Luca Burci
3
Events
23 June, 2020

Immunizing Global Health Against Disruptions

Global Health Centre
3
Events
21 May, 2020

Transparency and Access to Medicines: One Year After the WHA Resolution

Maison de la Paix
Global Health Centre and Suerie Moon
3
Events
18 November, 2021

The New Diplomacy of Global Health Q&A

Global Health Centre
316
News
28th April 2020

Debate: It’s Time for Us All to Fund the World Health Organization

Suerie Moon and Global Health Centre
3
Events
5 May, 2020

Will digital innovations be a game changer for pandemic surveillance and response?

Maison de la Paix
Global Health Centre
316
News
7th May 2020

What evolutionary institutionalism (and Charles Darwin) can tell us about COVID-19

Global Governance Centre and Velibor Jakovleski
316
Events
22 November, 2018

Antimicrobial Resistance in War Zones – A Call for Action

Maison de la Paix
Global Health Centre
3
Events
10 October, 2022

The long-term view: How to sustain local vaccine production for pandemics?

Maison de la Paix - Hybrid
Global Health Centre
Events
4–5 December 2017

A 1000 days of SDGs – Looking ahead

5 December, 2017
Global Health Centre
Close

Goal 3 seeks to “ensure health and well-being for all, at every stage of life. The Goal addresses all major health priorities, including reproductive, maternal and child health; communicable, non-communicable and environmental diseases; universal health coverage; and access for all to safe, effective, quality and affordable medicines and vaccines. It also calls for more research and development, increased health financing, and strengthened capacity of all countries in health risk reduction and management” as the UN Sustainable Development Knowledge Platform highlights. Read more about Goal 3.

Close
Target 3.1

By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births

Target 3.2

By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births

Target 3.3

By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases

Target 3.4

By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being

Target 3.5

Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol

Target 3.6

By 2020, halve the number of global deaths and injuries from road traffic accidents

Target 3.7

By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes

Target 3.8

Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all

Target 3.9

By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination

Target 3.a

Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate

Target 3.b

Support the research and development of vaccines and medicines for the communicable and noncommunicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

Target 3.c

Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States

Target 3.d

Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks